Rotavirus vaccination: short-term indirect herd protection, long-term uncertainty

Click to increase image sizeClick to decrease image size

Financial & competing interests disclosure

EJ Anderson has previously received funding for an investigator-initiated study proposal evaluating the burden of rotavirus in adults from Merck. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.

No writing assistance was utilized in the production of this manuscript.